• Research Use Only
  • All products currently listed on this site are for research purposes ONLY
  • Research Use Only
  • All products currently listed on this site are for research purposes ONLY
  • Research Use Only
  • All products currently listed on this site are for research purposes ONLY
  • Research Use Only
  • All products currently listed on this site are for research purposes ONLY
In Stock

Sema

Sema
Order Now, Ships Today
$69.00
One-time

Research Use Only

All products sold on this website are intended for research and identification purposes only and are not intended for human dosing, injections, or ingestion. These products are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for legitimate laboratory research and not for human or animal consumption.

What is

Sema

?

Sema, also known as Semaglutide, is a GLP-1 receptor agonist studied for its influence on metabolic signaling, appetite regulation, and insulin response. Research explores its role in modulating glucose uptake, energy balance, and endocrine function through peptide-mediated pathways.

Frequently asked questions

Products from Direct Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.

In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.

Need Help?

Send us a message.

Contact us

Sema Overview

Sema, also known as Semaglutide, is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1) that is structurally modified for extended activity. It is studied in laboratory and preclinical models for its ability to activate GLP-1 receptors, regulate insulin signaling, and modulate cellular pathways associated with glucose metabolism and endocrine regulation.

Marso S.P. et al. (2016).

Sema History

Research into GLP-1 biology began in the 1980s with the identification of its role in glucose regulation and endocrine signaling. Early synthetic GLP-1 receptor agonists demonstrated promise in extending receptor activation, but limited half-life restricted their utility. Semaglutide was later developed with structural modifications at specific amino acid positions to improve receptor binding and extend duration of action, making it a useful tool for studying incretin biology and metabolic pathways in research models.

Knudsen L.B. et al. (2000).

Sema Structure

CAS #: 910463-68-2

Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

Molecular Weight: 4113.6 g/mol

PubChem ID: 56843331

Sema Research Findings

Sema, also known as Semaglutide, has been studied in metabolic, endocrine, and cardiovascular models, with research highlighting its activity in glucose regulation, insulin secretion, and weight management pathways. Studies have also reported effects on lipid metabolism, appetite regulation, and cardiovascular outcomes in preclinical and clinical settings.

Key Areas of Research:

• Metabolic: glucose, insulin, energy balances

• Endocrine: GLP-1 signaling, hormone regulation

• Cardiovascular: lipid, cholesterol, outcomes

Together, these findings suggest broad experimental potential for Semaglutide across metabolic, endocrine, and cardiovascular pathways. By engaging GLP-1 signaling and influencing glucose and lipid metabolism, Semaglutide provides a versatile platform for research into metabolic regulation, cardiovascular health, and systemic resilience in laboratory models.

Wilding J.P.H. et al., 2021

Sema
Sema
$69.00